Hypoxia-induced oxidative stress promotes MUC4 degradation via autophagy to enhance pancreatic cancer cells survival

Pancreatic cancer (PC) and associated pre-neoplastic lesions have been reported to be hypoxic, primarily due to hypovascular nature of PC. Though the presence of hypoxia under cancerous condition has been associated with the overexpression of oncogenic proteins (MUC1), multiple emerging reports have also indicated the growth inhibitory effects of hypoxia. In spite of being recognized as the top-most differentially expressed and established oncogenic protein in PC, MUC4 regulation in terms of micro-environmental stress has not been determined. Herein, for the first time, we are reporting that MUC4 protein stability is drastically affected in PC, under hypoxic condition in a hypoxia inducible factor 1α (HIF-1α)-independent manner. Mechanistically, we have demonstrated that hypoxia-mediated induction of reactive oxygen species (ROS) promotes autophagy by inhibiting pAkt/mTORC1 pathway, one of the central regulators of autophagy. Immunohistofluorescence analyses revealed significant negative correlation (P-value=0.017) between 8-hydroxy guanosine (8-OHG) and MUC4 in primary pancreatic tumors (n=25). Moreover, we found pronounced colocalization between MUC4 and LAMP1/LC3 (microtubule-associated protein 1A/1B-light chain 3) in PC tissues and also observed their negative relationship in their expression pattern, suggesting that areas with high autophagy rate had less MUC4 expression. We also found that hypoxia and ROS have negative impact on overall cell growth and viability, which was partially, though significantly (P<0.05), rescued in the presence of MUC4. Altogether, hypoxia-mediated oxidative stress induces autophagy in PC, leading to the MUC4 degradation to enhance survival, possibly by offering required metabolites to stressed cells.

[1]  S. Batra,et al.  NCOA3-mediated upregulation of mucin expression via transcriptional and post-translational changes during the development of pancreatic cancer , 2014, Oncogene.

[2]  Xiaowei Zhang,et al.  Production of reactive oxygen species and 8-hydroxy-2'deoxyguanosine in KB cells co-exposed to benzo[a]pyrene and UV-A radiation. , 2004, Chemosphere.

[3]  Piperlongumine induces pancreatic cancer cell death by enhancing reactive oxygen species and DNA damage , 2014, Toxicology reports.

[4]  J. Nadel,et al.  Neutrophil Elastase Induces MUC5AC Mucin Production in Human Airway Epithelial Cells via a Cascade Involving Protein Kinase C, Reactive Oxygen Species, and TNF-α-Converting Enzyme1 , 2005, The Journal of Immunology.

[5]  M. Lenardo,et al.  Reactive oxygen species regulate autophagy through redox-sensitive proteases. , 2007, Developmental cell.

[6]  P. Vaupel,et al.  Hypoxia in cancer: significance and impact on clinical outcome , 2007, Cancer and Metastasis Reviews.

[7]  J. Meza,et al.  MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells. , 2008, Cancer research.

[8]  S. Batra,et al.  Altered Mucins (MUC) Trafficking in Benign and Malignant Conditions , 2014, Oncotarget.

[9]  M. V. Vander Heiden,et al.  Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein. , 2015, Cancer research.

[10]  H. Friess,et al.  Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  A. Jemal,et al.  Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[12]  P. Chaturvedi,et al.  Human MUC4 mucin induces ultra-structural changes and tumorigenicity in pancreatic cancer cells , 2007, British Journal of Cancer.

[13]  R. Tomasini,et al.  Hypoxia Induced Tumor Metabolic Switch Contributes to Pancreatic Cancer Aggressiveness , 2010, Cancers.

[14]  M. Plebani,et al.  Analogs of Vitamin E Epitomized by &agr;-Tocopheryl Succinate for Pancreatic Cancer Treatment: In Vitro Results Induce Caution for In Vivo Applications , 2010, Pancreas.

[15]  M. Hengartner,et al.  Apoptotic cell death under hypoxia. , 2014, Physiology.

[16]  S. Batra,et al.  Targeting EGF-receptor(s) - STAT1 axis attenuates tumor growth and metastasis through downregulation of MUC4 mucin in human pancreatic cancer , 2014, Oncotarget.

[17]  S. Batra,et al.  MUC4 potentiates invasion and metastasis of pancreatic cancer cells through stabilization of fibroblast growth factor receptor 1. , 2012, Carcinogenesis.

[18]  D. Tuveson,et al.  The promise and perils of antioxidants for cancer patients. , 2014, The New England journal of medicine.

[19]  S. Batra,et al.  Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy , 2012, Journal of Hematology & Oncology.

[20]  F. Cecconi,et al.  Oxidative stress and autophagy: the clash between damage and metabolic needs , 2014, Cell Death and Differentiation.

[21]  D. Stolz,et al.  Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability. , 2007, The American journal of pathology.

[22]  M. Hirota,et al.  Autophagy is needed for the growth of pancreatic adenocarcinoma and has a cytoprotective effect against anticancer drugs. , 2014, European journal of cancer.

[23]  S. Batra,et al.  Mucins in pancreatic cancer and its microenvironment , 2013, Nature Reviews Gastroenterology &Hepatology.

[24]  Erwin G. Van Meir Hypoxia-mediated selection of cells with diminished apoptotic potential to solid tumours. , 1996, Neurosurgery.

[25]  D. Bernard,et al.  MUC1, a new hypoxia inducible factor target gene, is an actor in clear renal cell carcinoma tumor progression. , 2009, Cancer research.

[26]  Christian M. Metallo,et al.  Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells , 2013, Nature.

[27]  S. Batra,et al.  Novel Interaction of MUC4 and Galectin: Potential Pathobiological Implications for Metastasis in Lethal Pancreatic Cancer , 2010, Clinical Cancer Research.

[28]  M. Colombo,et al.  A novel assay to study autophagy: regulation of autophagosome vacuole size by amino acid deprivation. , 2001, Journal of cell science.

[29]  D. Gupta,et al.  Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature , 2010, Nutrition journal.

[30]  G. Bhagat,et al.  Akt-Mediated Regulation of Autophagy and Tumorigenesis Through Beclin 1 Phosphorylation , 2012, Science.

[31]  H. Kasai Chemistry‐Based Studies on Oxidative DNA Damage: Formation, Repair, and Mutagenesis , 2010 .

[32]  S. Batra,et al.  Genetically engineered mucin mouse models for inflammation and cancer , 2015, Cancer and Metastasis Reviews.

[33]  J. Meza,et al.  Inhibition of MUC4 Expression Suppresses Pancreatic Tumor Cell Growth and Metastasis , 2004, Cancer Research.

[34]  E. Livingston,et al.  Predictors of early mortality in veteran patients with pancreatic cancer. , 2007, American journal of surgery.

[35]  P. Ge,et al.  Inhibition of autophagy induced by proteasome inhibition increases cell death in human SHG-44 glioma cells , 2009, Acta Pharmacologica Sinica.

[36]  R. Powers,et al.  MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer , 2012, Proceedings of the National Academy of Sciences.

[37]  F. Kaper,et al.  Anoxia is necessary for tumor cell toxicity caused by a low-oxygen environment. , 2005, Cancer research.

[38]  Jing-Jing Zhang,et al.  MUC4-induced nuclear translocation of β-catenin: a novel mechanism for growth, metastasis and angiogenesis in pancreatic cancer. , 2014, Cancer letters.

[39]  G. Semenza,et al.  Hypoxia-induced resistance to anticancer drugs is associated with decreased senescence and requires hypoxia-inducible factor-1 activity , 2008, Molecular Cancer Therapeutics.

[40]  Zhen-hua Hu,et al.  Autophagy-independent enhancing effects of Beclin 1 on cytotoxicity of ovarian cancer cells mediated by proteasome inhibitors , 2012, BMC Cancer.

[41]  E. Larsson,et al.  Antioxidants Accelerate Lung Cancer Progression in Mice , 2014, Science Translational Medicine.

[42]  M. Mimeault,et al.  MUC4 down-regulation reverses chemoresistance of pancreatic cancer stem/progenitor cells and their progenies. , 2010, Cancer letters.

[43]  E. Petricoin,et al.  The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cells , 2016, Oncogene.

[44]  D. Hailey,et al.  Autophagy termination and lysosome reformation regulated by mTOR , 2010, Nature.

[45]  S. Takao,et al.  MUC1 enhances hypoxia-driven angiogenesis through the regulation of multiple proangiogenic factors , 2013, Oncogene.

[46]  M. Ohue,et al.  Dormancy of Cancer Cells with Suppression of AKT Activity Contributes to Survival in Chronic Hypoxia , 2014, PloS one.

[47]  S. Kaur,et al.  For Peer Review MUC4 potentiates invasion and metastasis of pancreatic cancer cells through stabilization of fibroblast growth factor receptor 1 (FGFR1) , 2012 .

[48]  S. Batra,et al.  Expression of MUC17 Is Regulated by HIF1α-Mediated Hypoxic Responses and Requires a Methylation-Free Hypoxia Responsible Element in Pancreatic Cancer , 2012, PloS one.

[49]  Chang-Hoon Kim,et al.  Hypoxia-Mediated Mechanism of MUC5AC Production in Human Nasal Epithelia and Its Implication in Rhinosinusitis , 2014, PloS one.

[50]  C. Bauvy,et al.  Activation of lysosomal function in the course of autophagy via mTORC1 suppression and autophagosome-lysosome fusion , 2013, Cell Research.

[51]  M. Oka,et al.  Increased expression of MUC1 in advanced pancreatic cancer , 2003, Journal of Gastroenterology.

[52]  H. Elsässer,et al.  Monodansylcadaverine (MDC) is a specific in vivo marker for autophagic vacuoles. , 1995, European journal of cell biology.

[53]  Marc Liesa,et al.  Pancreatic cancers require autophagy for tumor growth. , 2011, Genes & development.